Companies: 10,795·Total market cap: $144.5T
BeOne Medicines Ltd.

BeOne Medicines Ltd.

ONCNASDAQHealthcare● Active
$269.86
$-0.24(-0.09%)
Market Cap$28.8B
P/E Ratio—
52W High$385.22
52W Low$239.25
Cash on HandFinancialsRevenue

BeOne Medicines Ltd. (ONC) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ONC · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$4.55B▲ +73.1% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$4.55B
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
+73.1%
vs prior fiscal year
Latest Quarter
$4.79B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$4.55BCash on Hand
Total Debt$2.00BTotal Debt
Net Cash / Net Debt+$2.55BNet Cash Position
Cash vs Debt Ratio
Cash 69%Debt 31%

BeOne Medicines Ltd. has a net cash position of $2.55B, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$4.55B − $2.00B = +$2.55B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ONC annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$4.55B+73.1%
Dec 31, 2024$2.63B-17.2%
Dec 31, 2023$3.17B-30.1%
Dec 31, 2022$4.53B-31.5%
Dec 31, 2021$6.62B+42.3%
ONC cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
BeOne Medicines Ltd.
BeOne Medicines Ltd.YOU
ONC
$4.55B15.7%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

BeOne Medicines Ltd. (ONC) cash on hand as of December 31, 2025 is $4.55B, comprising $4.55B in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as BeOne Medicines Ltd. cash and short-term investments on the balance sheet (10-K filing). Also referred to as BeOne Medicines Ltd. cash reserves or cash position.

BeOne Medicines Ltd. annual cash on hand history shows increased +73.1% in 2025: increased +73.1% in 2025. BeOne Medicines Ltd. cash reserves in 2025 reflect the company's capital allocation strategy.

BeOne Medicines Ltd. carries total debt of $2.00B against cash of $4.55B, resulting in a net cash position of +$2.55B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ONC cash on hand · 5 questions

As of December 31, 2025, BeOne Medicines Ltd. (ONC) has $4.55B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $4.55B in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (March 31, 2026): $4.79B. Data sourced from the annual 10-K filing via FMP.

ONC cash on handONC cash reservesONC cash 2025how much cash does ONC have

▸ Source: FMP /balance-sheet-statement · US GAAP · BeOne Medicines Ltd. · BeOne Medicines Ltd. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025